EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    1.13.11.11 | Alzheimer Disease |
33447045 |
The Effect of Tryptophan 2,3-Dioxygenase Inhibition on Kynurenine Metabolism and Cognitive Function in the APP23 Mouse Model of Alzheimer's Disease. |
ongoing research
unassigned |
2
0 |
| 1.13.11.11 | Anemia, Hemolytic |
14577161 |
[Activity of key enzymes of heme metabolism and cytochrome P-450 content in the rat liver in experimental rhabdomyolysis and hemolytic anemia] |
ongoing research
unassigned |
2
0 |
| 1.13.11.11 | Arthritis |
32055299 |
Recent advances in the discovery of indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors. |
causal interaction
therapeutic application
unassigned |
3
4
0 |
| 1.13.11.11 | Arthritis |
32924009 |
B-Cell-Targeted 3DNA Nanotherapy Against Indoleamine 2,3-Dioxygenase 2 (IDO2) Ameliorates Autoimmune Arthritis in a Preclinical Model. |
therapeutic application
unassigned |
1
0 |
| 1.13.11.11 | Aspergillosis |
31134053 |
Genetic Polymorphisms Affecting IDO1 or IDO2 Activity Differently Associate With Aspergillosis in Humans. |
diagnostic usage
unassigned |
3
0 |
| 1.13.11.11 | Asthma |
27161289 |
Tryptophan Metabolism in Allergic Disorders. |
causal interaction
therapeutic application
unassigned |
4
1
0 |
| 1.13.11.11 | Asthma |
30623620 |
Neopterin Levels and Indoleamine 2,3-Dioxygenase Activity as Biomarkers of Immune System Activation and Childhood Allergic Diseases. |
causal interaction
diagnostic usage
ongoing research
unassigned |
2
4
1
0 |
| 1.13.11.11 | Atherosclerosis |
31637003 |
The proatherosclerotic function of indoleamine 2, 3-dioxygenase 1 in the developmental stage of atherosclerosis. |
diagnostic usage
ongoing research
unassigned |
1
2
0 |
| 1.13.11.11 | Atherosclerosis |
32681019 |
The proatherosclerotic function of indoleamine 2, 3-dioxygenase 1 in the developmental stage of atherosclerosis. |
diagnostic usage
ongoing research
unassigned |
1
2
0 |
| 1.13.11.11 | Autoimmune Diseases |
22424783 |
An epigenetic mechanism for high, synergistic expression of indoleamine 2,3-dioxygenase 1 (IDO1) by combined treatment with zebularine and IFN-?: potential therapeutic use in autoimmune diseases. |
causal interaction
therapeutic application
unassigned |
3
4
0 |
